FGF2 transcript levels are positively correlated with EGF and IGF-1 in the malignant endometrium

Cancer Letters

Volumn 259, Issue 2, 2008, Pages 146-155

  Soufla, Giannoula ^a   Sifakis, Stavros ^b   Spandidos, Demetrios A ^a  

^a UNIVERSITY OF CRETE   (Greece)

^b UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

Author keywords

EGF; Endometrial cancer; FGF2; IGF 1; Real time PCR

Indexed keywords

EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 2; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; MESSENGER RNA; SOMATOMEDIN C;

ADULT; AGED; ANGIOGENESIS; ARTICLE; CANCER GRADING; CARCINOGENESIS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL TYPE; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENDOMETRIUM CARCINOMA; ENDOTHELIUM CELL; FEMALE; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; INTERMETHOD COMPARISON; METASTASIS; PRIORITY JOURNAL; QUANTITATIVE ASSAY; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, ENDOMETRIOID; DOWN-REGULATION; ENDOMETRIAL NEOPLASMS; ENDOMETRIUM; EPIDERMAL GROWTH FACTOR; FEMALE; FIBROBLAST GROWTH FACTOR 2; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MIDDLE AGED; POLYMERASE CHAIN REACTION; RNA, MESSENGER; UP-REGULATION;

EID: 37049027678     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2007.10.002     Document Type: Article

References (39)

1. Abulafia O., Triest W.E., and Sherer D.M. Angiogenesis in malignancies of the female genital tract. Gynecol. Oncol. 72 2 (1999) 220-231
2. Folkman J. Angiogenesis. J. Biol. Chem. 267 (1992) 10931-10934
3. Salvesen H.B., Iversen O.E., and Akslen L.A. Independent prognostic importance of microvessel density in endometrial carcinoma. Br. J. Cancer 77 (1998) 1140-1144
4. Kirschner C.V., Alanis-Amezcua J.M., Martin V.G., et al. Angiogenesis factor in endometrial carcinoma: a new prognostic indicator?. Am. J. Obstet. Gynecol. 174 (1996) 1879-1882
5. Gold L.I., Saxena B., Mittal K.R., et al. Increased expression of transforming growth factor beta isoforms and basic fibroblast growth factor in complex hyperplasia and adenocarcinoma of the endometrium: evidence for paracrine and autocrine action. Cancer Res. 1 54 9 (1994) 2347-2358
6. Pfeiffer D., Spranger J., Al Deiri M., et al. mRNA expression of Ligands of the epidermal-growth-factor receptor in the uterus. Int. J. Cancer 72 (1997) 581-586
7. Rutanen E.M. Insulin like growth factors in endometrial function. Gynecol. Endocrinol. 12 (1998) 399-406
8. Rutanen E.M. Insulin-like growth factors and insulin-like growth factor binding proteins in the endometrium. Effect of intrauterine levonorgestrel delivery. Hum. Reprod. 15 (2000) 173-181
9. Druckmann R., and Rohr U.D. IGF-1 in gynaecology and obstetrics: update 2002. Maturitas 41 (2002) S65-S83
10. Hirano S., Ito N., Takahashi S., and Tamaya T. Clinical implications of insulin-like growth factors through the presence of their binding proteins and receptors expressed in gynecological cancers. Eur. J. Gynaecol. Oncol. 25 2 (2004) 187-191
11. Giudice L.W., Irwin J.C., Dsupin B.A., et al. Insulin-like growth factor (IGF), IGF binding protein (IGFBP), and IGF receptor gene expression and IGFBP synthesis in human uterine leiomyomata. Hum. Reprod. 8 11 (1994) 1796-1806
12. Javerzat S., Auguste S., and Bikfalvi A. The role of fibroblast growth factors in vascular development. Trends Mol. Med. 8 (2002) 483-489
13. Soulitzis N., Karyotis I., Delakas D., and Spandidos D.A. Expression analysis of peptide growth factors VEGF, FGF2, TGFB1, EGF and IGF1 in prostate cancer and benign prostatic hyperplasia. Int. J. Oncol. 29 2 (2006) 305-314
14. Doll J.A., et al. Thrombospondin-1, vascular endothelial growth factor and fibroblast growth factor-2 are key functional regulators of angiogenesis in the prostate. Prostate 49 (2001) 293-305
15. Straume O., and Akslen L.A. Importance of vascular phenotype by basic fibroblast growth factor, and influence of the angiogenic factors basic fibroblast growth factor/fibroblast growth factor receptor-1 and EphA1/EphA2 on melanoma progression. Am. J. Pathol. 160 (2002) 1009-1019
16. Compagni A., et al. Fibroblast growth factors are required for efficient tumor angiogenesis. Cancer Res. 60 (2000) 7163-7169
17. Soufla G., Sifakis S., Baritaki S., Zafiropoulos A., Koumantakis E., and Spandidos D.A. VEGF, FGF2, TGFB1 and TGFBR1 mRNA expression levels correlate with the malignant transformation of the uterine cervix. Cancer Lett. 221 (2001) 105-118
18. Carmeliet P., and Rakesh J. Angiogenesis in cancer and other diseases. Nature 407 (2000) 249-257
19. Imai T., Kurachi H., Adachi K., et al. Changes in epidermal growth factor receptor and the levels of its ligands during menstrual cycle in human endometrium. Biol. Reprod. 52 (1995) 928-938
20. McBean J.H., Brumsted J.R., and Stirewalt W.S. In vitro estrogen regulation of epidermal growth factor receptor in human endometrium. J. Clin. Endocrinol. Metabol. 82 (1997) 1467-1471
21. Niikura H., Sasano H., Kaga K., et al. Expression of epidermal growth factor family proteins and epidermal growth factor receptor in human endometrium. Hum. Pathol. 27 (1996) 282-289
22. Moller B., Rasmussen C., and Olovsson M. Expression of the angiogenic growth factors VEGF, FGF-2, EGF and their receptors in normal human endometrium during the menstrual cycle. Mol. Hum. Reprod. 7 (2001) 65-72
23. Berchuck A., Rodriguez G., Kinney R.B., et al. Overexpression of HER-2/neu in endometrial cancer is associated with advanced stage disease. Am. J. Obstet. Gynecol. 164 (1991) 15-21
24. Khalifa M.A., Mannel R.S., Haraway S.D., Walker J., and Min K.W. Expression of EGFR, HER-2/neu, P53, and PCNA in endometrioid, serous papillary, and clear cell endometrial adenocarcinomas. Gynecol. Oncol. 53 (1994) 84-92
25. Mariani A., Sebo T.J., Katzmann J.A., Riehle D.L., Dowdy S.C., Keeney G.L., et al. HER-2/neu overexpression and hormone dependency in endometrial cancer: analysis of cohort and review of literature. Anticancer Res. 25 (2005) 2921-2927
26. Rolitsky C.D., Theil K.S., McGaughy V.R., Copeland L.J., and Niemann T.H. HER- 2/neu amplification and overexpression in endometrial carcinoma. Int. J. Gynecol. Pathol. 18 (1999) 138-143
27. Backe J., Gassel A.M., Krebs S., Muller T., and Caffier H. Immunohistochemically detected HER-2/neu-expression and prognosis in endometrial carcinoma. Arch. Gynecol. Obstet. 259 (1997) 189-195
28. Reinartz J.J., George E., Lindgren B.R., and Niehans G.A. Expression of p53, transforming growth factor alpha, epidermal growth factor receptor, and cerbB-2 in endometrial carcinoma and correlation with survival and known predictors of survival. Hum. Pathol. 25 (1994) 1075-1083
29. Pfeiffer D., Spranger J., Al Deiri M., Kimmig R., Fisseler-Eckhoff A., Scheidel P., et al. mRNA expression of ligands of the epidermal-growth factor-receptor in the uterus. Int. J. Cancer 72 (1997) 581-586
30. EjskJaer K., Sorensen B.S., Poulsen S.S., et al. Expression of the epidermal growth factor system in endometrioid endometrial cancer. Gynecol. Oncol. 104 (2007) 158-167
31. Reynolds R.K., Changzhi H., and Backer V. Transforming growth factor-a and insulin like growth factor-I, but not epidermal growth factor, elicit autocrine stimulation of mitogenesis in endometrial cancer cell lines. Gynecol. Oncol. 70 (1998) 202-209
32. Rutanen E.M., Nyman T., Lehtovirta P., et al. Suppressed expression of insulin like growth factor binding protein 1 mRNA in the endometrium: a molecular mechanism associating endometrial cancer with its risk factors. Int. J. Cancer 59 (1994) 307-312
33. Reynolds R.K., Owens C.A., Roberts J.A., et al. Cultured endometrial cells exhibit autocrine growth factor stimulation that is not observed in cultured normal endometrial cells. Gynecol. Oncol. 60 (1996) 380-386
34. Talavera F., Reynolds R.K., Roberts J.A., et al. Insulin-like growth factor-I receptors in normal and neoplastic human endometrium. Hum. Reprod. Update 9 (1994) 936-946
35. Yee D., Paik S., Lebovic G.S., et al. Analysis of insulin like growth factor-I gene expression in malignancy: evidence for a paracrine role in human breast cancer. Mol. Endocrinol. 3 (1989) 509-517
36. Yee D., Morales F.R., Hamilton T.C., et al. Expression of insulin like growth factor-1, its binding proteins and its receptor in ovarian cancer. Cancer Res. 51 (1991) 5107-5112
37. Maiorano E., Loverro G., Viale G., et al. Insulin-like growth factor-I expression in normal and diseased endometrium. Int. J. Cancer 80 (1999) 188-193
38. Fujimoto J., Hori M., Ichigo S., et al. Expression of basic fibroblast growth factor and its mRNA in uterine endometrial cancers. Invasion Metastasis 15 (1995) 203-210
39. Fujimoto J., Hori M., Ichigo S., et al. Expression of the fibroblast growth factor family (FGF-1, -2 and -4) mRNA in endometrial cancers. Tumour Biol. 17 (1996) 226-233